直接β-内酰胺灭活法:一种低成本快速检测血培养阳性瓶中产碳青霉烯酶或超广谱β-内酰胺酶肠杆菌目细菌的新方法
该研究验证并评估了一种名为直接β-内酰胺灭活法(dBLIM)的新表型试验,用于直接从肠杆菌目阳性血培养瓶中快速同步检测碳青霉烯酶或超广谱头孢菌素酶活性。研究使用422株特征明确的肠杆菌目菌株掺入需氧和厌氧血培养瓶进行评估,结果显示dBLIM对碳青霉烯酶和超广谱头孢菌素酶检测具有高灵敏度和100%特异性,尤其对KPC、OXA-48和NDM型碳青霉烯酶生产者检测效果优异。
要点
- dBLIM是一种低成本、高稳健性的表型筛查方法,可在血培养瓶阳性当天直接检测碳青霉烯酶或超广谱头孢菌素酶。
- dBLIM对碳青霉烯酶和超广谱头孢菌素酶检测的整体特异性为100%,未出现假阳性。
- 对VIM型碳青霉烯酶生产者,厌氧瓶灵敏度仅53.6%,需氧瓶为100%,需注意瓶型影响。
核心结论
- dBLIM可能是一种经济有效且高度稳健的表型筛查方法,可可靠地直接从血培养瓶检测碳青霉烯酶或超广谱头孢菌素酶,并在血培养瓶阳性当天获得结果。
研究设计与样本
- 研究验证并评估了一种名为直接β-内酰胺灭活法(dBLIM)的新表型试验,用于直接从肠杆菌目阳性血培养瓶中快速同步检测碳青霉烯酶或超广谱头孢菌素酶活性。
- dBLIM评估使用422株特征明确的肠杆菌目菌株掺入需氧和厌氧血培养瓶,菌株分为4个表型组:非产ESBL/ACBL/CARB的肠杆菌目(n=116)、产ESBL肠杆菌目(n=111)、产AmpCβ-内酰胺酶肠杆菌目(n=33)和产碳青霉烯酶肠杆菌目(n=162)。
主要发现
- 在非产ESBL/ACBL/CARB、产ESBL和产AmpC组中未获得假阳性结果,证明整体试验特异性为100%。
- 除表达VIM型碳青霉烯酶的肠杆菌目外,dBLIM在需氧和厌氧血培养瓶之间的性能在所有组中无显著差异。
- 在掺入携带blaVIM的肠杆菌目的血培养瓶中,dBLIM在厌氧瓶和需氧瓶中的灵敏度分别为53.6%和100%。
- 对于KPC、OXA-48和NDM型碳青霉烯酶生产者,无论测试瓶类型如何,dBLIM性能均被认为优异,灵敏度范围在99%至100%之间。
- 关于产ESBL和AmpC型超广谱头孢菌素酶的检测,dBLIM灵敏度分别为100%和84%至87%。
关键数值与推荐
- dBLIM检测超广谱β-内酰胺酶(ESBL)和碳青霉烯酶活性的临界值:5μg头孢噻肟纸片和10μg美罗培南纸片的抑菌圈直径均≤12 mm。
- dBLIM对碳青霉烯酶和超广谱头孢菌素酶检测的整体特异性为100%。
- 对VIM型碳青霉烯酶生产者,dBLIM在厌氧瓶和需氧瓶中的灵敏度分别为53.6%和100%。
- 对KPC、OXA-48和NDM型碳青霉烯酶生产者,dBLIM灵敏度范围在99%至100%之间。
- 对产ESBL和AmpC型超广谱头孢菌素酶的检测,dBLIM灵敏度分别为100%和84%至87%。
临床怎么用
- dBLIM可作为一种低成本、高稳健性的表型筛查方法,用于直接从血培养瓶可靠检测碳青霉烯酶或超广谱头孢菌素酶,并在血培养瓶阳性当天获得结果。
- 临床微生物实验室可考虑采用dBLIM直接从肠杆菌目阳性血培养瓶进行碳青霉烯酶和超广谱头孢菌素酶的快速表型检测。
- 对于VIM型碳青霉烯酶生产者,需注意厌氧瓶灵敏度较低(53.6%),建议优先使用需氧瓶进行dBLIM检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We validate and evaluate a new phenotypic assay, named the direct β-lactam inactivation method (dBLIM), for the rapid and simultaneous detection of carbapenemase or extended-spectrum-cephalosporinase activity directly from Enterobacterales (EB)-positive blood cultures (BCs). It originates from the carbapenem inactivation method (CIM), an inexpensive and highly sensitive assay for carbapenemase activity detection. dBLIM cutoff values to detect extended-spectrum β-lactamase (ESBL) and carbapenemase activities resulted in diameters of ≤12 mm for a 5-μg-cefotaxime disk and for a 10-μg-meropenem disk. dBLIM assessment was determined with both aerobic and anaerobic BC bottles spiked with 422 characterized EB strains, classifiable into the following 4 phenotypic groups: (i) ESBL/AmpC-type β-lactamase (ACBL)/carbapenemase (CARB)-nonproducing (np-ESBL/ACBL/CARB) EB (n = 116), (ii) ESBL-producing EB (n = 111), (iii) AmpC-β-lactamase-producing EB (n = 33), and (iv) carbapenemase-producing EB (n = 162). No false-positive results were obtained in any of the np-ESBL/ACBL/CARB EB, ESBL, and AmpC groups, demonstrating an overall assay specificity of 100%. There were no significant discrepancies in dBLIM performance between aerobic and anaerobic BCs across all groups, except with VIM-type carbapenemase-expressing EB. Interestingly, among BCs spiked with blaVIM-harboring EB, the sensitivity rates of the assay in anaerobic and aerobic bottles were 53.6% and 100%, respectively. In contrast, dBLIM performance was deemed excellent for the KPC, OXA-48, and NDM carbapenemase producers regardless of the type of bottle being tested, with a sensitivity rate ranging between 99% and 100%. Concerning the detection of the extended-spectrum cephalosporinases of the ESBL-producing and AmpC types, dBLIM sensitivities was 100% and 84 to 87%, respectively. dBLIM may be a cost-effective and highly robust phenotypic screening method for the reliable detection of carbapenemases or extended-spectrum cephalosporinases directly from BCs on the same day of bottle positivity detection.
引用
- Bianco G, Boattini M, Iannaccone M, et al. Direct β-Lactam Inactivation Method: a New Low-Cost Assay for Rapid Detection of Carbapenemase- or Extended-Spectrum-β-Lactamase-Producing Enterobacterales Directly from Positive Blood Culture Bottles. J Clin Microbiol. 2019. PMID: 31694972. doi:10.1128/JCM.01178-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。